Item 8.01 Other Events.
As previously announced, Watson Pharmaceuticals, Inc., a Nevada corporation (the "Company"), Robin Hood Holdings Limited, a Malta limited liability company ("Robin Hood"), the shareholders of Robin Hood (together, the "Sellers") and Anthony Selwyn Tabatznik, solely in his capacity as the Shareholders' Representative therein, entered into a definitive Share Purchase Agreement, dated as of June 16, 2009 (the "Share Purchase Agreement"). Pursuant to the Share Purchase Agreement, a wholly-owned subsidiary of Watson will acquire all of the outstanding equity of Robin Hood (the "Share Purchase") from the Sellers and thereby acquire the privately held Arrow Group, a group of global pharmaceutical companies. The Share Purchase remains subject to the satisfaction or waiver of the conditions to closing set forth in the Share Purchase Agreement.
In this Current Report on Form 8-K, the Company is incorporating by reference certain historical and pro forma financial information relating to the Share Purchase.
Item 9.01 Financial Statements and Exhibits
(a) Financial Statements of Robin Hood Holdings Limited

The consolidated financial statements of Robin Hood Holdings Limited and subsidiaries as of December 31, 2008 and 2007, and for each of the years in the two-year period ended December 31, 2008 are incorporated by reference in Exhibit 99.1 hereto and herein.
(b) Pro Forma Financial Statements

The unaudited pro forma condensed combined balance sheet of Watson Pharmaceuticals, Inc., as of June 30, 2009, and the unaudited pro forma combined statements of operations of Watson Pharmaceuticals, Inc., for the six months ended June 30, 2009 and the year ended December 31, 2008 are incorporated by reference in Exhibit 99.2 hereto and herein.
(d) Exhibits:

23.1 Consent of KPMG 99.1 Robin Hood Holdings Limited - Audited Consolidated Financial Statements (incorporated by reference to Exhibit 99.1 to the Company's Registration Statement on Form S-3 (File No. 333-161404), filed on August 17, 2009). 99.2 Watson Pharmaceuticals, Inc. - Unaudited Pro Forma Combined Financial Information (incorporated by reference to Exhibit 99.2 to the Company's Registration Statement on Form S-3 (File No. 333-161404), filed on August 17, 2009).

---